Clinical Trials Logo

Clinical Trial Summary

Small incision lenticule extraction (SMILE) is a refractive intrastromal procedure for myopia and myopic astigmatism correction. Most of the studies evaluating astigmatic correction by SMILE reported astigmatic under-correction, especially in high degrees of astigmatism. This under-correction could be due to: first, the active eye tracker or the iris registration is not yet available to overcome the cyclotorsion that occurred during the treatment with the VisuMax femtosecond laser system (Carl Zeiss Meditec, Jena, Germany) which could be overcome by manual compensation technique, especially in higher degrees of cylinders (> 1.5 diopters (D)). Second, in patients with small lenticule diameters, the more abrupt change in thickness at the edge of the treated area could induce more stromal and epithelial healing in this area. Thus, the astigmatic correction would be less effective with small than large lenticule diameters for similar high preoperative astigmatism. This study assessed the outcome of using a 0.5 millimeter (mm) larger lenticule diameter in the fellow eyes of myopic astigmatic correction SMILE participants. This assessment included the safety and effectiveness indices, the refractive and visual outcomes, the contrast sensitivity, and some morphological outcomes such as corneal curvature and epithelial and corneal thickness.


Clinical Trial Description

Study Title: Evaluation of different lenticule diameters in myopic astigmatic correction with SMILE procedures Primary Investigator: Dr. Ahmed Sedky (Eye Subspecialty Center, Cairo, Egypt, 18 Elkhalifa Elmamoun Street, Heliopolis, Cairo, Egypt) Co-Investigators: Sherine S Wahba, Maged M Roshdy, Nermeen A Refaat Study Objectives Primary Objective: To study the effect of changing the lenticule diameter on the safety and effectiveness of myopic astigmatism correction with the SMILE procedure. Secondary Objective: To compare other outcomes such as visual outcomes including immediate visual acuity, contrast sensitivity, and epithelial remodeling. Participants and Methods: Study Setting: Eye Subspecialty Center, Cairo, Egypt, 18 Elkhalifa Elmamoun Street, Heliopolis, Cairo, Egypt and Al Watany Eye Hospital, Althawra Street, Cairo, Egypt Study design: Hospital-based, comparative, prospective, interventional contralateral eye study Sample size and randomization: 50 participants fulfilling the inclusion criteria will be enrolled in the study. Their right eyes undergo SMILE procedure using the standard 6.5 mm lenticule diameter and their left eyes undergo SMILE procedure but using a larger lenticule diameter of 7.0 mm. Ethical issues: Institutional ethics committee approval will be obtained. Participants' informed consent will be taken and the procedure explained to them in their own language. Any intra-operative or post-operative complications occurring in either group will be documented and duly informed to the ethics committee Preoperative evaluation: 1. Anterior and posterior segment clinical examination 2. Uncorrected distance visual acuity (UDVA) in decimal and logMAR units 3. Corrected distance visual acuity (CDVA) in decimal and logMAR units 4. Corneal tomography using the Pentacam high resolution (HR) (Oculus Optikgeräte, Wetzlar, Germany) including the flattest and steepest meridians (in keratometric diopters (D), the axes (in degrees) 5. Contrast sensitivity (CSV1000E test (Good-Lite, Elgin, Illinois, USA)) in 4 different special frequencies 6. Anterior segment Optical Coherence Tomography (Cirrus, Carl Zeiss Meditec, Jena, Germany) measurement of total corneal and epithelial thickness in µm Study duration: 3 months for recruitment of the patients. Surgical technique: All surgeries will be performed under topical anesthesia using the VisuMax femtosecond laser with the following parameters: Cap thickness of 120 μm Cap diameter is either 7.5 mm for lenticule diameter 6.5 mm or 8.0 mm for lenticule diameter 7.0 mm. Cap side cut angle 70° 3 mm incision positioned at 100° and angled at 45° A transition zone of 0.1 mm and clearance of 0.5 mm Lenticule side cut angle of 90° and edge lenticule thickness of 15 μm Directly preoperative, the limbus will be marked in the 0° to 180° axis with a marker pen in the upright head position on the slit lamp. Then, the patient will be positioned under the VisuMax femtosecond laser and instructed to look into the green flashing fixation light. Once proper centration is achieved, the eye will be docked to the patient interface and suction will be applied. Manual compensation will be done by gently rotating the contact glass to align the horizontal marks on the eye to the 0° to 180° axis. Once both are aligned, the laser process will be done to create the refractive lenticule followed by its dissection and washing of the interface by a balanced salt solution. Medication: will be the standard treatment; topical steroids and antibiotics 4 times per day for 10 days and tear substitutes 4 times daily for one to two months. Postoperative evaluation: Follow-up of the subjects will be done in 1 day, 1 week, 3 months, and 6 months. Data will be collected for analysis starting from 1 week, including: 1. Uncorrected distance visual acuity (UDVA) in decimal and logMAR units 2. Corrected distance visual acuity (CDVA) in decimal and logMAR units 3. Corneal tomography using the Pentacam HR (Oculus Optikgeräte GmbH, Wetzlar, Germany) including the flattest and steepest meridians (in diopters (D), the axes (in degree) 4. Contrast sensitivity (CSV1000E test (Good-Lite, Elgin, IL, USA)) in 4 different special frequencies 5. Anterior segment Optical Coherence Tomography (Cirrus HD-OCT, Carl Zeiss Meditec, Jena, Germany) measurement of total corneal and epithelial thickness in µm. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06062004
Study type Interventional
Source Al Watany Eye Hospital
Contact Sherine Shafik, PhD
Phone 00201222421896
Email s_shafik@hotmail.com
Status Recruiting
Phase N/A
Start date November 27, 2018
Completion date April 30, 2024

See also
  Status Clinical Trial Phase
Completed NCT04532099 - Clinical Comparison of Two Daily Wear Frequent Replacement Silicone Hydrogel Soft Contact Lenses N/A
Completed NCT05039112 - Clinical Comparison of 2 Daily Disposable Toric Soft Contact Lenses N/A
Completed NCT03670303 - Trial of an Educational Intervention to Promote Spectacle Use Among Secondary School Children in Islamabad, Pakistan N/A
Completed NCT02255474 - Bifocal Lenses In Nearsighted Kids N/A
Not yet recruiting NCT03222661 - Direct Comparison of SVOne Obtained Refraction to Subjective Manifest Refraction N/A
Completed NCT04055519 - Clinical Performance Assessment of a Daily Wear Monthly Replacement Soft Silicone Hydrogel Contact Lens N/A
Recruiting NCT05049070 - Study to Evaluate the Reliability, Validity and Safety of Subjective Mobile Refraction N/A
Completed NCT04527978 - Clinical Comparison of 2 Daily Disposable Contact Lenses - Pilot Study 1 N/A
Completed NCT01430247 - Vision Screening for the Detection of Amblyopia N/A
Recruiting NCT06077682 - Cycloplegic Refraction in Pediatric Patients With Esotropia Phase 4
Not yet recruiting NCT04077086 - Correcting Myopia Among Secondary School Children to Increase Academic High School Attendance Rates in Rural Communities N/A
Withdrawn NCT04352868 - Customizing Myopia Control With Multifocal Toric Contact Lens N/A
Completed NCT04528017 - Clinical Comparison of 2 Daily Disposable Contact Lenses - Pilot Study 2 N/A
Recruiting NCT04338880 - Academic Performance and Refractive Error
Recruiting NCT04545073 - Outcomes of a Trifocal IOL in Post-refractive Patients
Enrolling by invitation NCT05992675 - Air Optix® Night and Day® Aqua Continuous Wear
Enrolling by invitation NCT05976750 - Air Optix® Night and Day® Aqua Daily Wear
Recruiting NCT04693247 - Handheld Device Compared With a Standard Eye Care Diagnostic Device in Measuring Ophthalmic Refraction N/A
Recruiting NCT06065631 - Seeing to Learn in Sierra Leone N/A
Not yet recruiting NCT05550740 - Repeated Low-Level Red-Light Therapy for Shortening Axial Length N/A